Search Results - "Charland, S L"

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial by Charland, S L, Agatep, B C, Herrera, V, Schrader, B, Frueh, F W, Ryvkin, M, Shabbeer, J, Devlin, J J, Superko, H R, Stanek, E J

“…Despite the clinical benefit of statin therapy and the numerous strategies used to improve adherence, no strategy has used direct communication of genetic test…”
Get full text

Acute pain management: operative or medical procedures and trauma by Follin, S L, Charland, S L

“…To review the topics presented in the Agency for Health Care Policy and Research (AHCPR) Clinical Practice Guideline for Acute Pain Management and provide…”
Get more information

Reversal of tumor-associated hyperglucagonemia as treatment for cancer cachexia by Bartlett, David L., Charland, Scott L., Torosian, Michael H.

“…Background. The tumor-bearing state is associated with increased circulating glucagon levels that may play an etiologic role in cancer cachexia. The secretion…”
Get full text

The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model by McDuffie, Robert S., Blanton, Sandra J., Charland, Scott L., Gibbs, Ronald S.

“…OBJECTIVE: Our purpose was to evaluate the effect of maternal administration of ampicillin-sulbactam on group B streptococcal colonization and bacteremia in…”
Get full text

Effect of Protein‐Calorie Malnutrition on Methotrexate Pharmacokinetics by Charland, Scott L., Bartlett, David, Torosian, Michael H.

“…Methotrexate toxicity is increased in protein‐calorie malnutrition. The influence of protein‐calorie malnutrition on the pharmacokinetics and binding of…”
Get full text

Possible inhibition of hepatic metabolism of quinidine by erythromycin by Spinler, S A, Cheng, J W, Kindwall, K E, Charland, S L

“…To present and analyze a patient case illustrating a possible drug interaction between quinidine and erythromycin. This is a case report of one hospitalized…”
Get more information

Is the Volume of Distribution of Digoxin Reduced in Patients with Renal Dysfunction? Determining Digoxin Pharmacokinetics by Fluorescence Polarization Immunoassay by Cheng, Judy W.M., Charland, Scott L., Shaw, Leslie M., Kobrin, Sidney, Goldfarb, Stanley, Stanek, Eric J., Spinier, Sarah A.

“…Study Objective. To determine digoxin pharmacokinetics in subjects with different degrees of renal function using fluorescence polarization immunoassay (FPIA),…”
Get full text

Low-Molecular-Weight Heparins in the Treatment of Pulmonary Embolism by Charland, Scott L, Klinter, Dawn EJ

“…More than 621 patients diagnosed with a PE have been treated with LMWH. This review included five randomized clinical trials (> 433 patients treated with LMWH)…”
Get full text

Activity of enoxaparin sodium in tuberculin syringes for 10 days by CHARLAND, S. L, DAVIS, D. D, TILLMAN, D. J

Get full text

Xanthine interference with dipyridamole-thallium-201 myocardial imaging by Stanek, E J, Melko, G P, Charland, S L

“…Both theophylline and caffeine have been shown to antagonize adenosine and are associated with false-negative test results with dipyridamole-T1-201 imaging…”
Get more information

A significant methotrexate-glutamine pharmacokinetic interaction by Charland, S L, Bartlett, D L, Torosian, M H

“…Previous studies indicate that glutamine-supplemented diets decrease the enterocolitis associated with methotrexate administration. The influence of glutamine…”
Get more information

The effect of parenteral nutrition on hepatic cytochrome P-450 by EARL-SALOTTI, G. L, CHARLAND, S. L

“…Total parenteral nutrition (TPN) has been shown to affect liver function tests. Additional investigations in animals and humans have demonstrated that hepatic…”
Get full text

Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma by Fabian, T C, Hess, M M, Croce, M A, Wilson, R S, Wilson, S E, Charland, S L, Rodman, J H, Boucher, B A

“…There were 73 evaluable patients entered into a prospective, double-blinded trial comparing aztreonam/clindamycin (A/C) to gentamicin/clindamycin (G/C) for the…”
Get more information

Effects of renal function on recainam pharmacokinetics and pharmacodynamics by Cheng, J W, Charland, S L, Goldfarb, S, Spinler, S A

“…To investigate the pharmacokinetics and pharmacodynamics of recainam, an investigational class I antiarrhythmic agent, in subjects with various degrees of…”
Get more information

Propafenone-theophylline interaction by Spinler, S A, Gammaitoni, A, Charland, S L, Hurwitz, J

“…A 63-year-old man with ventricular tachycardia (VT) refractory to drug therapy was admitted for surgical ablation of the VT with coronary artery bypass graft…”
Get more information

Predictive Performance of Ten Equations for Estimating Creatinine Clearance in Cardiac Patients by Spinler, Sarah A, Nawarskas, James J, Boyce, Eric G, Connors, John E, Charland, Scott L, Goldfarb, Stanley

“…OBJECTIVE: The predictive performance of 10 equations used to estimate creatinine clearance (Clcr) was assessed retrospectively from data collected on 420…”
Get full text

The Effect of Insulin-like Growth Factor-1 on Protein Metabolism and Hepatic Response to Endotoxemia in Parenterally Fed Rats by Dickerson, Roland N., Manzo, Claudia B., Charland, Scott L., Settle, R.Gregg, Stein, T.Peter, Kuhl, David A., Rajter, Jean-Jacques

“…To determine the influence of insulin-like growth factor-1 (IGF-1) on nitrogen loss and hepatic response to critical illness, 34 male Sprague-Dawley rats…”
Get full text

Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization by Tillman, D J, Charland, S L, Witt, D M

“…Controlled clinical trials have demonstrated that outpatient administration of low-molecular-weight heparin to patients with acute deep vein thrombosis (DVT)…”
Get more information

PCV74 ONE-YEAR COST-EFFECTIVENESS OF CYTOCHROME P450 2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROMES IN THE UNITED KINGDOM by Charland, SL, Agatep, B, Malone, D, Stanek, E

Get full text

PCV1 A MODIFIED RXRISK-V COMORBIDITY INDEX PREDICTS ADHERENCE WITH LIPID LOWERINGTHERAPY (LLT) by Ghate, S, LaFleur, J, Charland, SL, Sauer, B

Get full text